Alerts will be sent to your verified email
Verify Email
ANG
|
ANG Lifesciences
|
Mangalam Drugs&Org.
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.78 % | -0.44 % | 12.26 % |
|
5yr average Equity Multiplier
|
3.3 | 2.43 | 2.68 |
|
5yr Average Asset Turnover Ratio
|
0.77 | 1.0 | 0.93 |
|
5yr Avg Net Profit Margin
|
-2.26 % | 0.0 | 5.75 % |
|
Price to Book
|
0.66 | 0.31 | 0.92 |
|
P/E
|
0.0 | 0.0 | 10.98 |
|
5yr Avg Cash Conversion Cycle
|
70.26 Days | 17.41 Days | 138.58 Days |
|
Inventory Days
|
107.37 Days | 132.58 Days | 96.42 Days |
|
Days Receivable
|
274.82 Days | 38.43 Days | 135.23 Days |
|
Days Payable
|
235.98 Days | 126.53 Days | 103.44 Days |
|
5yr Average Interest Coverage Ratio
|
1.81 | 0.9 | 4.03 |
|
5yr Avg ROCE
|
15.08 % | 6.92 % | 17.72 % |
|
5yr Avg Operating Profit Margin
|
7.68 % | 7.63 % | 10.31 % |
|
5 yr average Debt to Equity
|
0.97 | 0.59 | 0.9 |
|
5yr CAGR Net Profit
|
n/a | 39.54 % | 50.43 % |
|
5yr Average Return on Assets
|
1.04 % | -0.18 % | 5.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.6 % | 50.3 % | 67.47 % |
|
Share Pledged by Promoters
|
44.88 % | 34.58 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.55 % | -0.12 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
ANG Lifesciences
|
Mangalam Drugs&Org.
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|